Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shu Narumiya"'
Autor:
Kazuya Nigoro, Hiromu Ito, Tomotoshi Kawata, Kohei Nishitani, Yasuharu Tabara, Fumihiko Matsuda, Shu Narumiya, Shuichi Matsuda, on behalf of the Nagahama Study group
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background In knee osteoarthritis (OA), pain is the most frequent and dominant symptom. However, which factors other than radiological changes contribute to the symptoms is unresolved. The aims of this study were to identify factors affectin
Externí odkaz:
https://doaj.org/article/8ebeddc42a2a46df86eba721f02a0a15
Autor:
Jing Hao Wong, Daichi Shigemizu, Yukiko Yoshii, Shintaro Akiyama, Azusa Tanaka, Hidewaki Nakagawa, Shu Narumiya, Akihiro Fujimoto
Publikováno v:
Genome Medicine, Vol 11, Iss 1, Pp 1-15 (2019)
Abstract Background Next-generation sequencing has allowed for the identification of different genetic variations, which are known to contribute to diseases. Of these, insertions and deletions are the second most abundant type of variations in the ge
Externí odkaz:
https://doaj.org/article/6e6ded06d44e426c815c8e48ffe41fe4
Autor:
Shinichiro Ishie, Tomoki Aoyama, Hiromu Ito, Yasuharu Tabara, Yugo Morita, Shu Narumiya, Tomotoshi Kawata, Kohei Nishitani, Kazuya Nigoro, Fumihiko Matsuda, Shuichi Matsuda
Publikováno v:
Cartilage
Objective: This cross-sectional study aimed to explore the differences of the medial and lateral sides of the knee joint and precise radiographic abnormalities in contribution to the knee pain and clinical outcomes. Design: Participants 60 years or o
Autor:
Yukiko Yoshii, Akihiro Fujimoto, Hidewaki Nakagawa, Daichi Shigemizu, Shintaro Akiyama, Jing Hao Wong, Shu Narumiya, Azusa Tanaka
Publikováno v:
Genome Medicine
Genome Medicine, Vol 11, Iss 1, Pp 1-15 (2019)
Genome Medicine, Vol 11, Iss 1, Pp 1-15 (2019)
Background Next-generation sequencing has allowed for the identification of different genetic variations, which are known to contribute to diseases. Of these, insertions and deletions are the second most abundant type of variations in the genome, but
Autor:
Kazuo Kunisawa, Yukihiro Noda, Kuniaki Saito, Tomoyuki Furuyashiki, Kiyofumi Yamada, Shu Narumiya, Yasuko Yamamoto, Toshitaka Nabeshima, Akihiro Mouri
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO3-1
Autor:
Hiroshi Nojima, Tomomi Yamaguchi-Miyamoto, Yumi Nishikawa, Yasushi Kuraishi, Shu Narumiya, Tsugunobu Andoh
Publikováno v:
Journal of Investigative Dermatology. 127:2042-2047
Thromboxane A2 (TXA2), a metabolite of arachidonic acid produced by cyclooxygenase and thromboxane synthase, is thought to participate in chronic dermatitis. This study investigated the involvement of TXA2 in cutaneous itch. An intradermal injection
Publikováno v:
The FASEB Journal. 21
Autor:
Tsugunobu ANDOH, Ai YAMAMOTO, Satomi HAZA, Koh-ichi YUHKI, Fumitaka USHIKUBI, Shu NARUMIYA, Yasushi KURAISHI
Publikováno v:
Acta Dermato-Venereologica; Nov2016, Vol. 96 Issue 7, p899-904, 6p
Autor:
Takafumi Ishibashi, Hiroshi Takayama, Shu Narumiya, Minoru Okuma, Fumitaka Ushikubi, Kenjiro Tomo
Publikováno v:
Hemostasis and Circulation ISBN: 9784431700968
Thromboxane A2 (TXA2), a major arachidonic acid (AA) metabolite in platelets, is a potent stimulator of platelet functions and constrictor of vascular and respiratory smooth muscles [1,2]. Because of such potent biological activities and its formatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9a29c664a027962f95ec780124fe33f
https://doi.org/10.1007/978-4-431-66925-8_17
https://doi.org/10.1007/978-4-431-66925-8_17
Publikováno v:
Japanese Journal of Pharmacology. 82:22